
Originally Posted by Custer Inc
Follow the link for the full media story
Originally Posted by Custer Inc
Follow the link for the full media story
Prostate cancer patients whose cancer has spread have a game-changing new option for treatment.
May 12, 2025
BAMF Health dosed the first patient in the U.S. for Radiopharm Theranostics’ Phase 2b imaging study of 18F-RAD101 in suspected recurrent brain metastasis.
April 28, 2025
This non-invasive clinical trial aims to understand the prevalence of a specific biomarker in HR-/HER2+ breast cancer.
April 24, 2025